The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer

12 of 46 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Breast Neoplasms; Fatigue; Nausea; Vomiting; Piperazines; Phthalazines; BRCA1 Protein; BRCA2 Protein; Mutation; Quality of Life; Female
PubMed ID
38301187
PubMed Central ID
PMC11095886
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal